eClinical news in brief

By Kirsty Barnes

- Last updated on GMT

Related tags: Clinical trial, Contract research organization, Edc

Outsourcing-Pharma tracks the latest eClinical movements, featuring
Phoenix Data Systems, Clinphone and Omnicomm Systems.

US contract research organisation (CRO) Bio-Imaging Technologies has bought eclincal firm Phoenix Data Systems​ for $24m. Phoenix delivers electronic data capture (EDC), interactive voice response (IVR), reporting, and data management services and last year generated a turnover of $12m. Bio-Imaging said that the global EDC services market is increasing rapidly and within five years the market is anticipated to hold over $1bn in potential. Mark Weinstein, Bio-Imaging's CEO said of the purchase: "We have had an interest to expand into the eclinical space for several years and have been looking for a company that meets our criteria, of: excellent reputation, strong management team, and comprehensive suite of products and services with growing profitable operations​". "The acquisition of Phoenix Data Systems expands our core clinical trial services business into the rapidly growing EDC market and leverages our global operational capabilities and sales and marketing reach into pharmaceutical and biotechnology companies​", he said. UK-based ClinPhone​ has just launched a new combined EDC and IVR/interactive web response (IWR) solution, which integrates two industry-leading solutions in the one package - ClinPhone's DataLabs (EDC) technology and its randomization, trial supply management and ePRO solutions (IVR/IWR). "This unique integrated offering provides significant benefits which enable sponsors to streamline the clinical trials process​", the company said. "ClinPhone's new combined EDC and IVR/IWR technology eliminates the traditional costs of integrating systems from multiple vendors​". According to the eclinical provider, "total assurance​" of the accuracy of data shared between applications is guaranteed through its Connect integration platform, complete with a full integration audit trail. Full visibility of the data integration process also ensures the quality and reliability of shared data, the company added. ClinPhone said it introduced the new combination package in direct response to "strong industry demand for solving key challenges associated with integration of clinical technologies​". "Using ClinPhone's innovative solution allows pharmaceutical sponsors to reduce the burden on their study teams by working with a single technology provider. It also offers pharmaceutical clients and end-users the benefit of dealing with a single in-house dedicated support help desk​", the firm said. OmniComm Systems​ has announced that medical devices-focused CRO Pleiad Devices has chosen it to be its preferred EDC vendor. The firm will use Omnicomm's TrialMaster EDC solution, with the first application being for an upcoming ophthalmology trial. Stephen Brandao, vice president of Business Development for Pleiad Devices said: "Over the years, our team has had experience with most of the EDC vendors in the marketplace. TrialMaster is one of the best EDC products that we have seen​..." No other terms of the arrangement were disclosed.

Related news

Show more

Related products

show more

Overcoming Challenges of Clinical Data Review

Overcoming Challenges of Clinical Data Review

PerkinElmer | 10-Jun-2021 | Technical / White Paper

Clinical data review is intrinsic to clinical development, assuring patient safety, determining drug efficacy, and assessing data quality. It involves...

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 09-Jun-2021 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-Jun-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Related suppliers

Follow us


View more